+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Majid Kazmi
BmedBiol MB ChB MRCP(UK) MRCPath
Haematology, Haematological (blood) cancers
Haematological stem cell transplantation (HSCT, BMT); myeloma; lymphoma (Non-Hodgkin's lymphoma; Hodgkin's lymphoma); Acute & chronic leukaemia (ALL, AML, CLL, CML); general haematology.
Dr Majid Kazmi is a Consultant Haematologist and the Director of the Blood and Marrow Transplant programme of Guy's and St Thomas' NHS Foundation Trust. He is also Clinical Director of Oncology & Haematology. Under his supervision the transplant programme has become the fastest growing programme in London and has undergone a successful inspection for accreditation under JACIE. His particular research interests are on transplantation in myeloma and auto-immune diseases. He has been involved in several anti-fungal studies.
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.